Freestyle Aortic Bioprostheses in Patients 60 Years old and Younger.


Journal

Seminars in thoracic and cardiovascular surgery
ISSN: 1532-9488
Titre abrégé: Semin Thorac Cardiovasc Surg
Pays: United States
ID NLM: 8917640

Informations de publication

Date de publication:
2022
Historique:
received: 30 07 2021
accepted: 02 08 2021
pubmed: 12 8 2021
medline: 19 8 2022
entrez: 11 8 2021
Statut: ppublish

Résumé

Evaluate outcomes of the Freestyle stentless aortic bioprosthesis in patients 60 years old and younger. All patients, 60 years old and younger, between January 1, 1998 to December 31, 2015 who underwent implantation of a Freestyle aortic valve at a single institution were reviewed. Medical records and telephone interviews were utilized for data collection. 515 patients were identified with an average age of 51.3 years. Mean follow up was 11.1 years. 225 full root replacements and 290 subcoronary implants were performed. Overall survival, including patients with concomitant procedures, at 15 years was 63.7% (95% CI 58.3-68.5). Isolated subcoronary implants (58%,167/290) had a 15-year survival of 71.6% (95% CI 62.6-78.7) vs 78.4% (95% CI 69.7, 84.9) for isolated root replacements (63%,141/225) which was not statistically significant (P = 0.397). No significant difference in operative SVD at 15 years occurred between full root replacements 37.6% (95% CI 27.2-50.2) vs subcoronary implants 39.4% (95% CI31.1, 49.0). 110 patients required reoperation solely for intrinsic SVD. 93% (102/110) failed due to aortic insufficiency. Of reoperative interventions for SVD, 37% (41/110) of patients required urgent reoperation and 4.5% (5/110) required emergent reoperation. Pseudoaneurysms developed in six of the full root replacements. Freestyle aortic valves have a high rate of acute failure requiring urgent or emergent reintervention in patients 60 years old and younger. This has led our group to shift practice away from their implantation.

Identifiants

pubmed: 34380081
pii: S1043-0679(21)00380-4
doi: 10.1053/j.semtcvs.2021.08.003
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

870-877

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Auteurs

Jawad Khazaal (J)

College of Human Medicine, Michigan State University, Grand Rapids.

Mary Ragagni (M)

Department of Cardiovascular Research, Spectrum Health, Grand Rapids.

Jessica Parker (J)

Office of Research and Education, Spectrum Health, Grand Rapids.

Tomasz Timek (T)

Department of Cardiothoracic Surgery, Spectrum Health, Grand Rapids.

Edward Murphy (E)

Department of Cardiothoracic Surgery, Spectrum Health, Grand Rapids.

John Heiser (J)

Department of Cardiothoracic Surgery, Spectrum Health, Grand Rapids.

Charles Willekes (C)

Department of Cardiothoracic Surgery, Spectrum Health, Grand Rapids. Electronic address: charles.willekes@spectrumhealth.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH